Workflow
国产乳业
icon
Search documents
妙可蓝多涨2.03%,成交额1.58亿元,主力资金净流出112.79万元
Xin Lang Cai Jing· 2025-10-31 05:59
Core Viewpoint - The stock price of Miaokelan Duo has increased by 43.13% year-to-date, with a recent trading volume indicating active market participation and a mixed flow of funds [2][1]. Company Overview - Miaokelan Duo, established on November 29, 1988, and listed on December 6, 1995, is located in Shanghai and specializes in the research, production, and sales of dairy products, primarily cheese [2]. - The company's main revenue sources are cheese (83.20%), trade (8.94%), liquid milk (7.29%), and others (0.57%) [2]. Financial Performance - For the period from January to September 2025, Miaokelan Duo reported a revenue of 3.957 billion yuan, representing a year-on-year growth of 10.09%, and a net profit attributable to shareholders of 176 million yuan, which is a significant increase of 106.88% year-on-year [2]. - The company has distributed a total of 368 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 13.85% to 39,100, with an average of 13,045 circulating shares per person, which decreased by 12.51% [2]. - Hong Kong Central Clearing Limited is noted as a new major shareholder, holding 6.1521 million shares [3].
南侨食品的前世今生:2025年三季度营收22.68亿排行业第四,净利润2882.13万排第七
Xin Lang Zheng Quan· 2025-10-30 14:35
Core Viewpoint - Nanqiao Food, established in 2010 and listed in 2021, is a leading company in the domestic baking oil sector, focusing on the research, production, and sales of baking oil products with a diverse and stable product range [1] Group 1: Business Performance - In Q3 2025, Nanqiao Food reported revenue of 2.268 billion yuan, ranking 4th in the industry, surpassing the industry average of 2.028 billion yuan but below the top competitors [2] - The main business composition includes baking oil at 701 million yuan (45.07%), dairy products at 346 million yuan (22.28%), and other products [2] - The net profit for the same period was 28.8213 million yuan, ranking 7th in the industry, below the industry average [2] Group 2: Financial Ratios - As of Q3 2025, the debt-to-asset ratio was 18.13%, lower than the previous year's 19.42% and significantly below the industry average of 35.61%, indicating strong solvency [3] - The gross profit margin was 19.01%, down from 24.47% year-on-year and below the industry average of 35.62%, suggesting a need for improvement in profitability [3] Group 3: Executive Compensation - The chairman, Chen Zhengwen, received a salary of 4.4 million yuan in 2024, an increase of 480,000 yuan from 2023 [4] - The general manager, Lin Changyu, had a salary of 2.02 million yuan in 2024, a decrease of 70,000 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 10.83% to 12,600, while the average number of shares held per shareholder increased by 12.14% to 33,600 [5] Group 5: Market Outlook - According to Zheshang Securities, the company experienced a slight revenue decline in H1 2025, with pressures on performance due to high raw material costs and changing end-user demand [6] - The company reported significant growth in pre-made baked goods and fillings, with revenues of 223 million yuan and 11 million yuan respectively, showing year-on-year increases [6] - The company aims to expand its global market presence, particularly in Southeast Asia, and forecasts revenues of 2.898 billion, 3.074 billion, and 3.206 billion yuan for 2025-2027, with corresponding net profits [6]
均瑶健康的前世今生:2025年三季度营收10.95亿行业排12,净利润亏损行业排14
Xin Lang Cai Jing· 2025-10-30 14:18
Core Viewpoint - Junyao Health is a well-known company in the domestic lactic acid beverage sector, focusing on the research, production, and sales of high-quality lactic acid drinks, with advanced production processes and strict quality control systems [1] Group 1: Business Performance - In Q3 2025, Junyao Health reported revenue of 1.095 billion yuan, ranking 12th in the industry, significantly lower than the top player Yili Group at 90.341 billion yuan and second-place Bright Dairy at 18.231 billion yuan [2] - The main business composition includes probiotic beverages at 261 million yuan (34.11%), supply chain products at 261 million yuan (34.07%), probiotic foods at 168 million yuan (21.98%), and other beverages and foods at 73.183 million yuan (9.55%) [2] - The net profit for the same period was -11.3712 million yuan, ranking 14th in the industry, with a notable gap compared to Yili Group's net profit of 10.42 billion yuan [2] Group 2: Financial Ratios - As of Q3 2025, Junyao Health's debt-to-asset ratio was 15.81%, lower than the previous year's 16.89% and significantly below the industry average of 41.11%, indicating strong solvency [3] - The gross profit margin for Q3 2025 was 31.18%, an increase from 29.81% in the previous year and higher than the industry average of 24.79% [3] Group 3: Executive Compensation - The chairman, Wang Junhao, received a salary of 3.1266 million yuan in 2024, a decrease of 78,100 yuan from 2023 [4] - The general manager, Yu Wei, earned a salary of 1.9935 million yuan in 2024 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 19.52% to 34,300, while the average number of circulating A-shares held per household increased by 24.25% to 17,500 [5] - Tianhong Zhongzheng Food and Beverage ETF ranked as the tenth largest circulating shareholder, holding 948,500 shares, an increase of 116,700 shares from the previous period [5]
妙可蓝多的前世今生:2025年三季度营收39.57亿低于行业平均,净利润1.76亿高于中位数
Xin Lang Cai Jing· 2025-10-30 13:30
Core Viewpoint - Miaokelando is a leading company in the domestic cheese industry, focusing on the research, production, and sales of cheese-based dairy products, with a strong brand presence and diverse product matrix [1] Group 1: Business Performance - In Q3 2025, Miaokelando reported revenue of 3.957 billion yuan, ranking 5th in the industry, below the industry average of 7.469 billion yuan [2] - The main business composition includes cheese revenue of 2.136 billion yuan (83.20%), trade revenue of 230 million yuan (8.94%), and liquid milk revenue of 187 million yuan (7.29%) [2] - The net profit for the same period was 176 million yuan, ranking 4th in the industry, exceeding the industry median of 46.41 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Miaokelando's debt-to-asset ratio was 45.40%, higher than the previous year's 43.36% and the industry average of 41.11% [3] - The gross profit margin for Q3 2025 was 29.88%, an increase from 28.93% in the previous year and above the industry average of 24.79% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 13.85% to 39,100 [5] - The average number of circulating A-shares held per shareholder decreased by 12.51% to 13,000 [5] Group 4: Strategic Outlook - Analysts from Guangfa Securities highlight Miaokelando's strategic transformation and collaboration with Mengniu, predicting revenue growth from 5.486 billion yuan in 2025 to 7.214 billion yuan in 2027, with corresponding net profits increasing significantly [5] - Guohai Securities anticipates revenue growth of 10% to 14% from 2025 to 2027, with net profit projections showing substantial increases [5]
一鸣食品的前世今生:2025年三季度营收21.46亿元,行业排名6/19,低于行业平均53.23亿元
Xin Lang Cai Jing· 2025-10-30 13:22
Core Viewpoint - Yiming Foods, a leading player in the domestic dairy industry, has established a unique model of "fresh dairy products + baked goods" and possesses a full industry chain advantage from raw material supply to retail [1] Group 1: Business Performance - In Q3 2025, Yiming Foods reported a revenue of 2.146 billion yuan, ranking 6th among 19 companies in the industry [2] - The company's main business composition includes dairy products at 660 million yuan (47.09%), baked goods at 434 million yuan (30.95%), other foods at 172 million yuan (12.31%), and chain operations at 34.2 million yuan (2.44%) [2] - The net profit for the same period was 46.41 million yuan, placing it 10th in the industry [2] Group 2: Financial Ratios - As of Q3 2025, Yiming Foods had a debt-to-asset ratio of 61.43%, higher than the industry average of 41.11% [3] - The gross profit margin was 28.95%, which, although slightly lower than the previous year's 29.58%, remains above the industry average of 24.79% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 12.44% to 28,700 [5] - The average number of circulating A-shares held per shareholder increased by 14.21% to 14,000 [5] - Notable shareholders include Hong Kong Central Clearing Limited and Tianhong Zhongzheng Food and Beverage ETF, with respective holdings of 1.5143 million shares and 475,200 shares [5] Group 4: Executive Compensation - The chairman, Zhu Like, received a salary of 1.0695 million yuan in 2024, an increase of 34,800 yuan from the previous year [4]
贝因美跌2.02%,成交额1.68亿元,主力资金净流出2690.00万元
Xin Lang Cai Jing· 2025-10-30 05:20
Core Viewpoint - Beiyinmei's stock price has experienced fluctuations, with a year-to-date increase of 50.12%, but recent trading shows a decline in the short term [1][2]. Company Overview - Beiyinmei Co., Ltd. is located in Hangzhou, Zhejiang Province, and was established on April 27, 1999, with its stock listed on April 12, 2011. The company specializes in the research, production, and sales of infant food and milk-based nutritional products [1]. - The main revenue composition includes: milk powder 89.20%, other (supplements) 4.69%, rice cereal 3.54%, supplies 1.71%, and other categories 0.86% [1]. Financial Performance - For the period from January to September 2025, Beiyinmei achieved operating revenue of 2.033 billion yuan, a year-on-year decrease of 2.59%. However, the net profit attributable to shareholders increased by 48.07% to 106 million yuan [2]. - Since its A-share listing, Beiyinmei has distributed a total of 961 million yuan in dividends, with no dividends paid in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders increased to 147,900, with an average of 7,302 circulating shares per person, a decrease of 3.14% from the previous period [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 9.1823 million shares, an increase of 4.3616 million shares from the previous period, and Tianhong Zhongzheng Food and Beverage ETF, holding 4.2728 million shares, an increase of 52,320 shares [3]. Market Activity - On October 30, Beiyinmei's stock price fell by 2.02% to 6.32 yuan per share, with a trading volume of 168 million yuan and a turnover rate of 2.45%, resulting in a total market capitalization of 6.826 billion yuan [1]. - The stock has appeared on the trading leaderboard 24 times this year, with the most recent appearance on August 7, where it recorded a net purchase of 17.7676 million yuan [1].
科拓生物跌2.05%,成交额5630.78万元,主力资金净流出744.60万元
Xin Lang Zheng Quan· 2025-10-30 02:51
Core Viewpoint - Keta Bio's stock price has shown fluctuations, with a year-to-date increase of 21.15% and a recent decline over the past 20 days, indicating mixed market sentiment towards the company [1][2]. Company Overview - Keta Bio, established on September 5, 2003, and listed on July 27, 2020, is located in Beijing and specializes in the research, production, and sales of food additives, probiotics, and micro-ecological preparations for plants and animals [1]. - The company's revenue composition includes 71.03% from probiotics, 16.96% from micro-ecological preparations, 11.14% from food additives, 0.73% from probiotic technology services, and 0.14% from other sources [1]. Financial Performance - For the period from January to September 2025, Keta Bio reported a revenue of 267 million yuan, reflecting a year-on-year growth of 22.25%, while the net profit attributable to shareholders was 76.23 million yuan, up 7.08% year-on-year [2]. - Since its A-share listing, Keta Bio has distributed a total of 289 million yuan in dividends, with 132 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Keta Bio had 17,100 shareholders, an increase of 5.63% from the previous period, with an average of 11,343 circulating shares per shareholder, down 5.33% [2]. - Among the top ten circulating shareholders, the "Fuguo Growth Navigation Mixed Fund" holds 6.6083 million shares, unchanged from the previous period, while the "Fuguo Balanced Preferred Mixed Fund" reduced its holdings by 3.1617 million shares to 4.2466 million shares [3].
贝因美涨2.05%,成交额2.48亿元,主力资金净流出792.22万元
Xin Lang Zheng Quan· 2025-10-29 06:36
Core Viewpoint - Beiyinmei's stock price has shown significant fluctuations, with a year-to-date increase of 53.68%, while recent trading activity indicates mixed investor sentiment [1][2]. Group 1: Stock Performance - As of October 29, Beiyinmei's stock price rose by 2.05% to 6.47 CNY per share, with a trading volume of 248 million CNY and a turnover rate of 3.60%, resulting in a total market capitalization of 6.988 billion CNY [1]. - Year-to-date, Beiyinmei's stock has increased by 53.68%, with a 0.94% rise over the last five trading days, a 3.69% increase over the last 20 days, and a 3.72% decline over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Beiyinmei reported a revenue of 2.033 billion CNY, a year-on-year decrease of 2.59%, while the net profit attributable to shareholders increased by 48.07% to 106 million CNY [2]. - The company has distributed a total of 961 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, Beiyinmei had 147,900 shareholders, an increase of 3.24% from the previous period, with an average of 7,302 circulating shares per shareholder, a decrease of 3.14% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 9.1823 million shares, an increase of 4.3616 million shares from the previous period [3].
熊猫乳品跌2.00%,成交额2733.53万元,主力资金净流入95.90万元
Xin Lang Cai Jing· 2025-10-29 02:31
Core Viewpoint - Panda Dairy's stock price has shown a decline recently, with a year-to-date increase of only 3.23%, indicating potential volatility in the market [1][2]. Financial Performance - As of September 30, Panda Dairy reported a revenue of 586 million yuan for the first nine months of 2025, reflecting a year-on-year growth of 3.00% [2]. - The company's net profit attributable to shareholders was 71.71 million yuan, which represents a year-on-year decrease of 8.17% [2]. Stock Market Activity - On October 29, Panda Dairy's stock price fell by 2.00%, trading at 25.92 yuan per share, with a total market capitalization of 3.214 billion yuan [1]. - The stock has experienced a decline of 10.31% over the past 60 days, with a recent trading volume of 27.34 million yuan [1]. Shareholder Information - The number of shareholders for Panda Dairy decreased by 14.02% to 17,000 as of September 30, while the average number of circulating shares per person increased by 16.30% to 6,748 shares [2]. Dividend Distribution - Since its A-share listing, Panda Dairy has distributed a total of 205 million yuan in dividends, with 161 million yuan distributed over the past three years [3].
温氏股份涨2.00%,成交额5.47亿元,主力资金净流出1182.58万元
Xin Lang Cai Jing· 2025-10-27 02:57
Core Viewpoint - The stock of Wens Foodstuff Group Co., Ltd. has shown a mixed performance in recent trading, with a year-to-date increase of 12.56% but a slight decline in the last five and twenty trading days [1][2]. Financial Performance - For the period from January to September 2025, Wens achieved a revenue of 75.817 billion yuan, reflecting a year-on-year growth of 0.53%. However, the net profit attributable to shareholders decreased by 17.98% to 5.256 billion yuan [2]. - Cumulative cash dividends since the A-share listing amount to 28.116 billion yuan, with 4.942 billion yuan distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Wens was 81,100, a decrease of 10.94% from the previous period. The average number of circulating shares per person increased by 12.11% to 73,543 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 144 million shares, an increase of 5.5013 million shares compared to the previous period. Conversely, E Fund's ChiNext ETF reduced its holdings by 19.091 million shares to 113 million shares [3]. Stock Performance - As of October 27, Wens' stock price was 18.36 yuan per share, with a market capitalization of 122.166 billion yuan. The stock experienced a 2.00% increase during the trading session [1]. - The stock has seen a trading volume of 547 million yuan, with a turnover rate of 0.50% [1].